AVIDITY BIOSCIENCES INC (RNA) Stock Analyst Ratings
NASDAQ:RNA - Nasdaq - US05370A1088 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 85% to RNA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 68.2. This target is 103.17% above the current price.
RNA was analyzed by 20 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about RNA.
In the previous month the buy percentage consensus was at a similar level.
RNA was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-07-10 | Goldman Sachs | Reiterate | Buy |
| 2025-06-27 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-06-17 | Wolfe Research | Initiate | Outperform |
| 2025-06-11 | Raymond James | Initiate | Strong Buy |
| 2025-06-10 | Barclays | Maintains | Overweight -> Overweight |
| 2025-06-10 | Citigroup | Maintains | Buy -> Buy |
| 2025-06-09 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-06-09 | B of A Securities | Maintains | Buy -> Buy |
| 2025-05-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-09 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-07 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-04-09 | Needham | Reiterate | Buy -> Buy |
| 2025-03-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-17 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-17 | Needham | Reiterate | Buy -> Buy |
| 2025-03-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-13 | Citigroup | Initiate | Buy |
| 2025-03-12 | BMO Capital | Initiate | Outperform |
| 2025-03-10 | B of A Securities | Maintains | Buy -> Buy |
| 2025-03-07 | ScotiaBank | Initiate | Sector Outperform |
| 2025-02-28 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-02-28 | Barclays | Maintains | Overweight -> Overweight |
| 2025-01-21 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-01-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-20 | HC Wainwright & Co. | Initiate | Buy |
| 2024-11-26 | RBC Capital | Initiate | Outperform |
| 2024-11-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-11-13 | Needham | Reiterate | Buy -> Buy |
| 2024-10-31 | Needham | Reiterate | Buy -> Buy |
| 2024-10-30 | Chardan Capital | Maintains | Buy -> Buy |